Liu Z, Mahale P, Engels EA. Sepsis and risk of cancer among elderly adults in the United States. Clin Infect Dis. 2019;68(5):717–24. https://doi.org/10.1093/cid/ciy530.
Article CAS PubMed Google Scholar
Mirouse A, Vigneron C, Llitjos JF, Chiche JD, Mira JP, Mokart D, et al. Sepsis and cancer: an interplay of friends and foes. Am J Respir Crit Care Med. 2020;202(12):1625–35. https://doi.org/10.1164/rccm.202004-1116TR.
Vigneron C, Mirouse A, Merdji H, Rousseau C, Cousin C, Alby-Laurent F, et al. Sepsis inhibits tumor growth in mice with cancer through Toll-like receptor 4-associated enhanced natural killer cell activity. Oncoimmunology. 2019;8(11): e1641391. https://doi.org/10.1080/2162402x.2019.1641391.
Article CAS PubMed PubMed Central Google Scholar
Danahy DB, Jensen IJ, Griffith TS, Badovinac VP. Cutting edge: polymicrobial sepsis has the capacity to reinvigorate tumor-infiltrating CD8 T cells and prolong host survival. J Immunol. 2019;202(10):2843–8. https://doi.org/10.4049/jimmunol.1900076.
Article CAS PubMed Google Scholar
Buzás K, Marton A, Vizler C, Gyukity-Sebestyén E, Harmati M, Nagy K, et al. Bacterial sepsis increases survival in metastatic melanoma: chlamydophila pneumoniae induces macrophage polarization and tumor regression. J Invest Dermatol. 2016;136(4):862–5. https://doi.org/10.1016/j.jid.2015.12.032.
Article CAS PubMed Google Scholar
Hensley MK, Donnelly JP, Carlton EF, Prescott HC. Epidemiology and outcomes of cancer-related versus non-cancer-related sepsis hospitalizations. Crit Care Med. 2019;47(10):1310–6. https://doi.org/10.1097/ccm.0000000000003896.
Article PubMed PubMed Central Google Scholar
Mendonça MA, Cunha FQ, Murta EF, Tavares-Murta BM. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy. Cancer Chemother Pharmacol. 2006;57(5):663–70. https://doi.org/10.1007/s00280-005-0086-4.
Article CAS PubMed Google Scholar
Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565–70. https://doi.org/10.1126/science.1203486.
Article CAS PubMed Google Scholar
Camou F, Didier M, Leguay T, Milpied N, Daste A, Ravaud A, et al. Long-term prognosis of septic shock in cancer patients. Support Care Cancer. 2020;28(3):1325–33. https://doi.org/10.1007/s00520-019-04937-4.
Vincent JL. Current sepsis therapeutics. EBioMedicine. 2022;86: 104318. https://doi.org/10.1016/j.ebiom.2022.104318.
Article CAS PubMed PubMed Central Google Scholar
Giudice A, Aliberti SM, Barbieri A, Pentangelo P, Bisogno I, D’Arena G, et al. Potential mechanisms by which glucocorticoids induce breast carcinogenesis through Nrf2 inhibition. Front Biosci. 2022;27(7):223. https://doi.org/10.31083/j.fbl2707223.
Dietrich K, Schned A, Fortuny J, Heaney J, Marsit C, Kelsey KT, et al. Glucocorticoid therapy and risk of bladder cancer. Br J Cancer. 2009;101(8):1316–20. https://doi.org/10.1038/sj.bjc.6605314.
Article CAS PubMed PubMed Central Google Scholar
Phares TW, Kotraiah V, Chung CS, Unsinger J, Mazer M, Remy KE, et al. A peptide-based checkpoint immunomodulator alleviates immune dysfunction in murine polymicrobial sepsis. Shock. 2021;55(6):806–15. https://doi.org/10.1097/shk.0000000000001682.
Article CAS PubMed PubMed Central Google Scholar
Shindo Y, McDonough JS, Chang KC, Ramachandra M, Sasikumar PG, Hotchkiss RS. Anti-PD-L1 peptide improves survival in sepsis. J Surg Res. 2017;208:33–9. https://doi.org/10.1016/j.jss.2016.08.099.
Article CAS PubMed Google Scholar
Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y, et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA. 2009;106(15):6303–8. https://doi.org/10.1073/pnas.0809422106.
Article PubMed PubMed Central Google Scholar
Hotchkiss RS, Colston E, Yende S, Angus DC, Moldawer LL, Crouser ED, et al. Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559). Crit Care Med. 2019;47(5):632–42. https://doi.org/10.1097/ccm.0000000000003685.
Article CAS PubMed PubMed Central Google Scholar
Hotchkiss RS, Colston E, Yende S, Crouser ED, Martin GS, Albertson T, et al. Immune checkpoint inhibition in sepsis: a phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. Intensive Care Med. 2019;45(10):1360–71. https://doi.org/10.1007/s00134-019-05704-z.
Article CAS PubMed PubMed Central Google Scholar
He J, Qin W, Jiang S, Lin Y, Lin Y, Yang R, et al. Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathway. Drug Dev Res. 2024;85(4): e22219. https://doi.org/10.1002/ddr.22219.
Article CAS PubMed Google Scholar
Chen MH, Gu YY, Zhang AL, Sze DM, Mo SL, May BH. Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer. Pharmacol Res. 2021;171: 105778. https://doi.org/10.1016/j.phrs.2021.105778.
Article CAS PubMed Google Scholar
Li ST, Dai Q, Zhang SX, Liu YJ, Yu QQ, Tan F, et al. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway. Acta Pharmacol Sin. 2018;39(8):1294–304. https://doi.org/10.1038/aps.2017.143.
Article CAS PubMed PubMed Central Google Scholar
Wang H, Sun X, Gao F, Zhong B, Zhang YH, Sun Z. Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB. J Exp Clin Cancer Res. 2012;31(1):2. https://doi.org/10.1186/1756-9966-31-2.
Article CAS PubMed PubMed Central Google Scholar
Xu J, Peng Y, Yang M, Guo N, Liu H, Gao H, et al. Increased levels of myeloid-derived suppressor cells in esophageal cancer patients is associated with the complication of sepsis. Biomed Pharmacother. 2020;125: 109864. https://doi.org/10.1016/j.biopha.2020.109864.
Article CAS PubMed Google Scholar
Liu MA, Bakow BR, Hsu TC, Chen JY, Su KY, Asiedu EK, et al. Temporal trends in sepsis incidence and mortality in patients with cancer in the US population. Am J Crit Care. 2021;30(4):e71–9. https://doi.org/10.4037/ajcc2021632.
Martín-Fernández M, Tamayo-Velasco Á, Aller R, Gonzalo-Benito H, Martínez-Paz P, Tamayo E. Endothelial dysfunction and neutrophil degranulation as central events in sepsis physiopathology. Int J Mol Sci. 2021;22(12):6272. https://doi.org/10.3390/ijms22126272.
Article CAS PubMed PubMed Central Google Scholar
Dunzendorfer S, Schratzberger P, Reinisch N, Kähler CM, Wiedermann CJ. Pentoxifylline differentially regulates migration and respiratory burst activity of the neutrophil. Ann N Y Acad Sci. 1997;832:330–40. https://doi.org/10.1111/j.1749-6632.1997.tb46261.x.
Article CAS PubMed Google Scholar
Bone RC. Inhibitors of complement and neutrophils: a critical evaluation of their role in the treatment of sepsis. Crit Care Med. 1992;20(6):891–8.
Article CAS PubMed Google Scholar
Hua Y, Liu D, Zhang D, Wang X, Wei Q, Qin W. Extracellular AMP suppresses endotoxemia-induced inflammation by alleviating neutrophil activation. Front Immunol. 2020;11:1220. https://doi.org/10.3389/fimmu.2020.01220.
留言 (0)